Patent ID: 6251956
Filing Date: 2001-06-26
Classification: A61K,Y10S

Abstract:
A combination progestin and estrogen hormonal method for human contraception involving the sequential administration of two or more different progestational agents in combination with an estrogen comprising the steps of:(a) administering a contraceptively effective amount of an endometrial sparing progestin in combination with an estrogen in single daily doses for a period of 7-14 days followed by;(b) administering a contraceptively effective amount of an atrophizing progestin in combination with an estrogen in single daily doses for a period of 7-14 days;(c) repeating steps (a) and (b) for a period of 21-90 days;(d) withdrawing the administration for a period of about seven days; and(e) repeating steps (a)-(d) continuously.